• Je něco špatně v tomto záznamu ?

Oligoclonal free light chains in cerebrospinal fluid as markers of intrathecal inflammation. Comparison with oligoclonal IgG

D. Zeman, P. Hradilek, P. Kusnierova, R. Piza, K. Reguliova, I. Woznicova, O. Zapletalova

. 2015 ; 159 (1) : 104-113. [pub] 20141205

Jazyk angličtina Země Česko

Typ dokumentu srovnávací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17006051

AIMS: To compare the sensitivity and specificity of CSF-restricted oligoclonal IgG and free light chains as markers of multiple sclerosis and other inflammatory neurological diseases. METHODS: 196 paired CSF and serum samples were examined for oligoclonal IgG and oligoclonal free light chains. The sensitivity and specificity of the tests were calculated and optimal cut-offs for the number of CSF-restricted oligoclonal bands were then determined by analysis of receiver operating characteristic curves. RESULTS: Optimal cut-off values were ≥5 IgG bands for multiple sclerosis, ≥4 IgG bands for inflammatory neurological disease, ≥6 free κ, and ≥2 free λ bands for both purposes. Using these cut-off values, sensitivities and specificities for multiple sclerosis were 83.8% and 91.3% for IgG, 83.8% and 81.0% for free κ, and 67.6% and 75.4% for free λ. For inflammatory neurological disease, sensitivities and specificities were 60.8% and 95.7% for IgG, 69.6% and 92.6% for free κ, and 64.8% and 86.2% for free λ. CONCLUSIONS: Although exact cut-off values may vary according to method, reporting borderline results as positive, may compromise the specificity of the test and should be avoided.. The detection of intrathecal free light chain synthesis may be of value especially when the oligoclonal IgG test is negative or borderline, even though its specificity is slightly lower.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17006051
003      
CZ-PrNML
005      
20170308085057.0
007      
ta
008      
170210s2015 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2014.058 $2 doi
035    __
$a (PubMed)25485529
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Zeman, David $u Department of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic; Clinic of Neurology, University Hospital Ostrava; Department of Clinical Biochemistry, Institute of Laboratory Medicine, University Hospital Ostrava $7 mzk2018988719
245    10
$a Oligoclonal free light chains in cerebrospinal fluid as markers of intrathecal inflammation. Comparison with oligoclonal IgG / $c D. Zeman, P. Hradilek, P. Kusnierova, R. Piza, K. Reguliova, I. Woznicova, O. Zapletalova
520    9_
$a AIMS: To compare the sensitivity and specificity of CSF-restricted oligoclonal IgG and free light chains as markers of multiple sclerosis and other inflammatory neurological diseases. METHODS: 196 paired CSF and serum samples were examined for oligoclonal IgG and oligoclonal free light chains. The sensitivity and specificity of the tests were calculated and optimal cut-offs for the number of CSF-restricted oligoclonal bands were then determined by analysis of receiver operating characteristic curves. RESULTS: Optimal cut-off values were ≥5 IgG bands for multiple sclerosis, ≥4 IgG bands for inflammatory neurological disease, ≥6 free κ, and ≥2 free λ bands for both purposes. Using these cut-off values, sensitivities and specificities for multiple sclerosis were 83.8% and 91.3% for IgG, 83.8% and 81.0% for free κ, and 67.6% and 75.4% for free λ. For inflammatory neurological disease, sensitivities and specificities were 60.8% and 95.7% for IgG, 69.6% and 92.6% for free κ, and 64.8% and 86.2% for free λ. CONCLUSIONS: Although exact cut-off values may vary according to method, reporting borderline results as positive, may compromise the specificity of the test and should be avoided.. The detection of intrathecal free light chain synthesis may be of value especially when the oligoclonal IgG test is negative or borderline, even though its specificity is slightly lower.
650    _2
$a biologické markery $x mok mozkomíšní $7 D015415
650    _2
$a lidé $7 D006801
650    _2
$a imunoglobulin G $x mok mozkomíšní $7 D007074
650    _2
$a roztroušená skleróza $x mok mozkomíšní $7 D009103
650    _2
$a oligoklonální proužky $x mok mozkomíšní $7 D043025
650    _2
$a reprodukovatelnost výsledků $7 D015203
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hradílek, Pavel $7 xx0076908 $u Clinic of Neurology, University Hospital Ostrava
700    1_
$a Kušnierová, Pavlína, $d 1978- $7 xx0140526 $u Department of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic; Department of Clinical Biochemistry, Institute of Laboratory Medicine, University Hospital Ostrava
700    1_
$a Píža, Radim $7 _AN040313 $u Clinic of Neurology, University Hospital Ostrava
700    1_
$a Reguliova, Katarina $u Clinic of Neurology, University Hospital Ostrava
700    1_
$a Woznicová, Ivana $7 xx0269339 $u Clinic of Neurology, University Hospital Ostrava
700    1_
$a Zapletalová, Olga, $d 1947- $7 utb2009546667 $u Clinic of Neurology, University Hospital Ostrava
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 159, č. 1 (2015), s. 104-113
856    41
$u http://biomed.papers.upol.cz/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20170210 $b ABA008
991    __
$a 20170223104127 $b ABA008
999    __
$a ok $b bmc $g 1192581 $s 966698
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 159 $c 1 $d 104-113 $e 20141205 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20170210

Najít záznam

Citační ukazatele

Možnosti archivace